Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-09-08 Sale | 2021-09-09 4:15 pm | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 11,000 | $28.45 | $312,950 | 581,548 (Indirect Direct) | View |
| 2021-08-10 Sale | 2021-08-26 7:11 pm | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 11,000 | $27 | $297,000 | 592,548 (Indirect Direct) | View |
| 2019-12-27 Sale | 2019-12-30 5:32 pm | Harpoon Therapeutics Inc. | HARP | Baeuerle Patrick Director | 87,379 | $15.98 | $1,396,281 | 262,136 (Indirect) | View |
| 2019-12-20 Sale | 2019-12-26 5:30 pm | TCR2 THERAPEUTICS INC. | TCRR | Baeuerle Patrick Director | 116,929 | $15.36 | $1,796,418 | 350,786 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-02-17 Option Award | 2023-02-21 6:53 pm | N/A 2033-02-16 | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick Chief Scientific Officer | 115,500 | $0 | 494,434 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:48 pm | N/A 2032-02-10 | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 112,500 | $0 | 453,934 (Direct) | View |
| 2021-09-08 Exercise | 2021-09-09 4:15 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 11,000 | $4.3 | 581,548 (Direct) | View |
| 2021-09-08 Exercise | 2021-09-09 4:15 pm | N/A 2030-10-28 | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 11,000 | $0 | 581,548 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-26 7:11 pm | N/A N/A | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 11,000 | $4.3 | 592,548 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-26 7:11 pm | N/A 2030-10-28 | Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks | 11,000 | $0 | 592,548 (Direct) | View |
| 2021-01-07 Option Award | 2021-01-11 5:37 pm | N/A 2031-01-06 | Cullinan Management Inc. | CGEM | Baeuerle Patrick See Remarks | 286,665 | $0 | 286,665 (Direct) | View |
Ownership | 2021-01-07 8:34 pm | N/A N/A | Cullinan Management Inc. | CGEM | Baeuerle Patrick See Remarks | 0 | $0 | 1,011,541 (Indirect) | View |
| 2020-12-10 Option Award | 2020-12-11 06:16 am | N/A 2030-12-09 | TCR2 THERAPEUTICS INC. | TCRR | Baeuerle Patrick Director | 12,100 | $0 | 362,886 (Direct) | View |
| 2020-05-28 Option Award | 2020-06-01 9:38 pm | N/A 2030-05-27 | Harpoon Therapeutics Inc. | HARP | Baeuerle Patrick Director | 12,751 | $0 | 12,751 (Direct) | View |